Serum dehydroepiandrosterone sulfate concentration as an indicator of adrenocortical suppression during inhaled steroid therapy in adult asthmatic patients

European Journal of Endocrinology

Volumn 150, Issue 5, 2004, Pages 687-690

  Kannisto, Senja ^a   Laatikainen, Anne ^a   Taivainen, Antti ^a   Savolainen, Kari ^a   Tukiainen, Hannu ^a   Voutilainen, Raimo ^a  

^a KUOPIO UNIVERSITY HOSPITAL   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN; BUDESONIDE; ESTROGEN; GLUCOCORTICOID; HORMONE PRECURSOR; HYDROCORTISONE; PRASTERONE SULFATE;

ADRENAL SUPPRESSION; ADULT; AGED; ANDROGEN SYNTHESIS; ARTICLE; ASTHMA; BLOOD ANALYSIS; CLINICAL TRIAL; CONCENTRATION (PARAMETERS); CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DRUG MEGADOSE; FEMALE; FORCED EXPIRATORY VOLUME; HUMAN; LOW DRUG DOSE; MAJOR CLINICAL STUDY; MALE; OSTEOPOROSIS; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RISK ASSESSMENT; TREATMENT OUTCOME;

ADMINISTRATION, INHALATION; ADRENAL CORTEX; ADULT; AGED; ASTHMA; BRONCHODILATOR AGENTS; BUDESONIDE; DEHYDROEPIANDROSTERONE SULFATE; DOSE-RESPONSE RELATIONSHIP, DRUG; DOUBLE-BLIND METHOD; FEMALE; FORCED EXPIRATORY VOLUME; HUMANS; HYDROCORTISONE; MALE; MIDDLE AGED; OSMOLAR CONCENTRATION;

EID: 2942707641     PISSN: 08044643     EISSN: None     Source Type: Journal    
DOI: 10.1530/eje.0.1500687     Document Type: Article

References (25)

1. Haahtela T Järvinen M. Kava T, Kiviranta K, Koskinen S, Lehtonen K et al. Comparison of a beta 2-agonist, terbutaline, with an inhaled corticosteroid, budesonide, in newly detected asthma. New England Journal of Medicine 1991 325 388-392.
2. Keeley D & Rees J. New guidelines on asthma management. British Medical Journal 1997 314 315-316.
3. Tukiainen H, Taivainen A, Majander R, Poussa T, Svahn T, Puolijoki H et al. Comparison of high and low dose of the inhaled steroid, budesonide, as an initial treatment in newly detected asthma. Respiratory Medicine 2000 94 678-683.
4. van der Molen T, Meyboom-de Jong B, Mulder HH & Postma DS. Starting with a higher dose of inhaled corticosteroids in primary care asthma treatment. American Journal of Respiratory and Critical Care Medicine 1998 158 121-125.
5. Kannisto S, Korppi M. Remes K & Voutilainen R. Adrenal suppression, evaluated by a low dose adrenocorticotropin test, and growth in asthmatic children treated with inhaled steroids. Journal of Clinical Endocrinology and Metabolism 2000 85 652-657.
6. Laatikamen AK, Kroger HP. Tukiainen HO, Honkanen RJ & Saarikoski SV. Bone mineral density in perimenopausal women with asthma: a population-based cross-sectional study. American Journal of Respiratory and Critical Care Medicine 1999 159 1179-1185.
7. Richy F, Bousquet J, Ehrlich GE, Meunier PJ, Israel E, Morii H et al. Inhaled corticosteroids effects on bone in asthmatic and COPD patients: a quantitative systemic review. Osteoporosis International 2003 14 179-190.
8. Rittmaster RS & Givner ML. Effect of daily and alternate day low dose prednisone on serum cortisol and adrenal androgens in hirsute women. Journal of Clinical Endocrinology and Metabolism 1988 67 400-403.
9. Kannisto S, Korppi M, Remes K & Voutilainen R. Serum dehydroepiandrosterone sulfate concentration as an indicator of adrenocortical suppression in asthmatic children treated with inhaled steroids. Journal of Clinical Endocrinology and Metabolism 2001 86 4908-4912.
10. Smith BJ, Buxton JR, Dickeson J & Heller RE Does beclomethasone dipropionate suppress dehydroepiandrosterone sulphate in postmenopausal women? Australian and New Zealand Journal of Medicine 1994 24 396-401.
11. Dunn PJ, Mahood CB, Speed JF & Jury DR. Dehydroepiandrosterone sulphate concentrations in asthmatic patients: pilot study. New Zealand Medical Journal 1984 97 805-808.
12. American Thoracic Society, Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease (COPD) and asthma. American Review of Respiratory Diseases 1987 136 225-244.
13. Pedersen S & Hansen OR. Budesonide treatment of moderate and severe asthma in children: a dose-response study. Journal of Allergy and Clinical Immunology 1995 95 29-33.
14. Haahtela T, Järvinen M, Kava T, Kiviranta K, Koskinen S. Lehtonen K et al. Effects of reducing or discontinuing inhaled budesonide in patients with mild asthma. New England Journal of Medicine 1994 331 700-705.
15. Pedersen B. Dahl R, Karlstrom R, Peterson CG & Venge P. Eosinophil and neutrophil activity in asthma in a one-year trial with inhaled budesonide. The impact of smoking. American Review of Respiratory Diseases 1996 153 1519-1529.
16. Ferguson AC, Spier S, Manjra A, Versteegh FG, Mark S & Zhang P. Efficacy and safety of high-dose inhaled steroids in children with asthma: a comparison of fluticasone propionate with budesonide. Journal of Pediatrics 1999 134 422-427.
17. Broide J, Soferman R, Kivity S, Golander A, Dickstein G. Spirer Z et al. Low-dose adrenocorticotropin test reveals impaired adrenal function in patients taking inhaled corticosteroids. Journal of Clinical Endocrinology and Metabolism 1995 80 1243-1246.
18. Mayenknecht J, Diederich S, Bähr V, Plöckinger U & Oelkers W, Comparison of low and high dose corticotropin stimulation tests in patients with pituitary disease. Journal of Clinical Endocrinology and Metabolism 1998 83 1558-1562.
19. Nasrallah MP & Arafah BM. The value of dehydroepiandrosterone sulfate measurements in the assessment of adrenal function. Journal of Clinical Endocrinology and Metabolism 2003 88 5293-5298.
20. Straub RH, Lehle K, Herfarth H, Weber M, Falk W, Preuner J et al. Dehydroepiandrosterone in relation to other adrenal hormones during an acute inflammatory stressful disease state compared with chronic inflammatory disease: role of interleukin-6 and turnour necrosis factor. European Journal of Endocrinology 2002 146 365-374.
21. Moriyama Y, Yasue H, Yoshimura M, Mizuno Y, Nishiyama K, Tsunoda R et al. The plasma levels of dehydroepiandrosterone sulfate are decreased in patients with chronic heart failure in proportion to the severity. Journal of Clinical Endocrinology and Metabolism 2000 85 1834-1840.
22. Cutler GB Jr, Davis SE, Johnsonbaugh RE & Loriaux DL. Dissociation of cortisol and adrenal androgen secretion in patients with secondary adrenal insufficiency. Journal of Clinical Endocrinology and Metabolism 1979 49 604-609.
23. Rittmaster RS, Loriaux DL & Cutler GB Jr. Sensitivity of cortisol and adrenal androgens to dexamethasone suppression in hirsute women. Journal of Clinical Endocrinology and Metabolism 1985 61 462-466.
24. Dickerman Z, Grant DR, Faiman C & Winter JS. Intraadrenal steroid concentrations in man: zonal differences and developmental changes. Journal of Clinical Endocrinology and Metabolism 1984 59 1031-1036.
25. Allolio B & Arlt W. DHEA treatment: myth or reality? Trends in Endocrinology and Metabolism 2002 13 288-294.